Weetabix Food Company UK & Ireland has appointed Claire Canty as the new Head of Innovation. Claire, who has a number of accolades under her belt – including 2016 Marketing Academy Scholar, The Grocer’s Top New Talent 2016 and Marketing Week’s Rising Star of the Year 2015 – has been at Weetabix for four years.
Her latest appointment sees Claire move from a cross-functional role as part of the Sales team, working on the Waitrose and Co-op accounts, back into the marketing team, where she began her Weetabix career.
Claire originally joined Weetabix Food Company from Nestle Confectionery four years ago as Senior Brand Manager for Weetabix Minis and Weetabix Original, where she led a range of very successful campaigns driving growth ahead of category and laying the foundations for Weetabix to become a £150million brand, which was achieved earlier this year.
As Head of Innovation for Weetabix Food Company UK & Ireland, Claire will be responsible for delivering this year’s NPD plan, as well as developing Weetabix’s five-year Innovation & Renovation pipeline. Claire replaces Paul Aikens, who stepped down from his role in May 2017.
Marketing Director, Sally Abbott said: “I’m delighted to announce Claire’s new role as Head of Innovation. Having generated great successes already in the marketing and commercial teams, and with so many outstanding accolades under her belt it’s easy to see why Claire has rapidly risen through the ranks. Her sheer determination, drive and passion set her up well to head up the Innovation team and we look forward to seeing her continued progress with the support of the business.”
Claire Canty said: “The Weetabix Food Company has a fantastic track record of innovation – Weetabix Protein won Product of the Year last year and our latest NPD, Weetabix Additions is set to be even more successful. I’m looking forward to the new challenges that the role will bring (no two days are ever the same) and delivering more exciting new products to our customers. Together with an excellent team we’re aiming to continue Weetabix’s growth journey and to remain the number one player in this challenging category.”